Lv41
458 积分 2025-03-02 加入
An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors
4天前
已完结
Development of Glypican 3–Targeting Antibody–Drug Conjugates for Hepatocellular Carcinoma Therapy
2个月前
已完结
IL1RAP antibody-drug conjugates potently target primary and metastatic disease in multiple oncofusion-driven cancers
3个月前
已完结
Interleukin-1 alpha-induced modulation of topoisomerase I activity and DNA damage: implications in the mechanisms of synergy with camptothecins in vitro and in vivo
3个月前
已完结
Interleukin-1 alpha-induced modulation of topoisomerase I activity and DNA damage: implications in the mechanisms of synergy with camptothecins in vitro and in vivo
3个月前
已关闭
Diagnosis and Treatment Response Monitoring of Liver Cancer Using Glypican-3–Targeted Single-Domain Antibody PET
5个月前
已完结
CD22-targeted CD28 bispecific antibody enhances antitumor efficacy of odronextamab in refractory diffuse large B cell lymphoma models
5个月前
已完结
uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell target
5个月前
已完结
A GPC1-targeted and gemcitabine-loaded Biocompatible Nanoplatform for Pancreatic Cancer Multimodal Imaging and Therapy
6个月前
已完结
Contactin-4 suppresses antitumor T cell responses by engaging amyloid precursor protein
6个月前
已完结